Rotarix (RIX4414): an oral human rotavirus vaccine (Q34574852)

3 August 2017

1 reference

title

Rotarix (RIX4414): an oral human rotavirus vaccine (English)

1 reference

3 August 2017

1 reference

Miguel O'Ryan

1

1 reference

3 August 2017

1 February 2007

1 reference

Expert Review of Vaccines

3 August 2017

1 reference

3 August 2017

6

1 reference

3 August 2017

11-19

1 reference

3 August 2017

1

1 reference

Global Illness and Deaths Caused by Rotavirus Disease in Children

3 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Rotavirus and severe childhood diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Where and why are 10 million children dying every year?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Rotavirus vaccines: current prospects and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Cost effectiveness of rotavirus vaccination in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Diarrhea- and Rotavirus-Associated Hospitalizations Among Children Less Than 5 Years of Age: United States, 1997 and 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.1.11

21 January 2018

Identifiers

DOI

10.1586/14760584.6.1.11

1 reference

3 August 2017

1 reference

PubMed ID

17280473